Big Rock Partners Acquisition Corp Releases Shareholder Vote Info
by Kristi Marvin on 2019-05-22 at 6:24pm

This afternoon, Big Rock Partners Acquisition Corp. (BRPA), released the details of their shareholder vote to approve their extension deadline to August 22, 2019, from May 22, 2019.  Big Rock has extended twice now, for $0.10 for each 3-month extension, however, this time around they will be extending for $0.02 per month for the next three months, or an aggregate of $95,604.50 each month.

Per the 8-K, holders of 2,119,772 shares of the Company’s common stock exercised their right to convert their shares into cash at a conversion price of approximately $10.43 per share, for an aggregate conversion amount of $22,099,233.09.  That means there is approximately $42,627,476 left in trust, but the additional $95,604.50 was also added to the trust as of today.

Big Rock now has an extra three months to announce a deal and close, but three months is tight so unless they announce something ASAP, another extension is most likely in their future.

You can review the results of all the vote proposals HERE.

 

Proposal to approve the business combination:
FORAGAINSTABSTAINBroker Non-Votes
6,196,187272,27300

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved